关注
Sudheer Kumar Gara
Sudheer Kumar Gara
National Cancer Institute, NIH, Bethesda
在 mail.nih.gov 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Three novel collagen VI chains with high homology to the α3 chain
SK Gara, P Grumati, A Urciuolo, P Bonaldo, B Kobbe, M Koch, ...
Journal of Biological Chemistry 283 (16), 10658-10670, 2008
2122008
TGF-β signaling in myeloid cells is required for tumor metastasis
Y Pang, SK Gara, BR Achyut, Z Li, HH Yan, CP Day, JM Weiss, ...
Cancer discovery 3 (8), 936-951, 2013
1702013
Germline HABP2 mutation causing familial nonmedullary thyroid cancer
SK Gara, L Jia, MJ Merino, SK Agarwal, L Zhang, M Cam, D Patel, ...
New England Journal of Medicine 373 (5), 448-455, 2015
1462015
Expression of the collagen VI α5 and α6 chains in normal human skin and in skin of patients with collagen VI-related myopathies
P Sabatelli, SK Gara, P Grumati, A Urciuolo, F Gualandi, R Curci, ...
Journal of Investigative Dermatology 131 (1), 99-107, 2011
992011
Expression of collagen VI α5 and α6 chains in human muscle and in Duchenne muscular dystrophy-related muscle fibrosis
P Sabatelli, F Gualandi, SK Gara, P Grumati, A Zamparelli, E Martoni, ...
Matrix Biology 31 (3), 187-196, 2012
972012
Gr‐1+ CD11b+ cells are responsible for tumor promoting effect of TGF‐β in breast cancer progression
Z Li, Y Pang, SK Gara, BR Achyut, C Heger, PK Goldsmith, S Lonning, ...
International journal of cancer 131 (11), 2584-2595, 2012
822012
miR30a inhibits LOX expression and anaplastic thyroid cancer progression
M Boufraqech, N Nilubol, L Zhang, SK Gara, SM Sadowski, A Mehta, ...
Cancer research 75 (2), 367-377, 2015
802015
Differential and restricted expression of novel collagen VI chains in mouse
SK Gara, P Grumati, S Squarzoni, P Sabatelli, A Urciuolo, P Bonaldo, ...
Matrix Biology 30 (4), 248-257, 2011
772011
Metastatic adrenocortical carcinoma displays higher mutation rate and tumor heterogeneity than primary tumors
SK Gara, J Lack, L Zhang, E Harris, M Cam, E Kebebew
Nature Communications 9 (1), 4172, 2018
672018
Dual inhibition of HDAC and tyrosine kinase signaling pathways with CUDC-907 inhibits thyroid cancer growth and metastases
S Kotian, L Zhang, M Boufraqech, K Gaskins, SK Gara, M Quezado, ...
Clinical Cancer Research 23 (17), 5044-5054, 2017
632017
Analysis of GTPases carrying hydrophobic amino acid substitutions in lieu of the catalytic glutamine: implications for GTP hydrolysis
R Mishra, SK Gara, S Mishra, B Prakash
Proteins: Structure, Function, and Bioinformatics 59 (2), 332-338, 2005
582005
RARRES2 functions as a tumor suppressor by promoting β-catenin phosphorylation/degradation and inhibiting p38 phosphorylation in adrenocortical carcinoma
Y Liu-Chittenden, M Jain, K Gaskins, S Wang, MJ Merino, S Kotian, ...
Oncogene 36 (25), 3541-3552, 2017
542017
The knee osteoarthritis susceptibility locus DVWA on chromosome 3p24. 3 is the 5′ part of the split COL6A4 gene
R Wagener, SK Gara, B Kobbe, M Paulsson, F Zaucke
Matrix Biology 28 (6), 307-310, 2009
532009
Distinct genome‐wide methylation patterns in sporadic and hereditary nonfunctioning pancreatic neuroendocrine tumors
A Tirosh, S Mukherjee, J Lack, SK Gara, S Wang, MM Quezado, ...
Cancer 125 (8), 1247-1257, 2019
402019
A mouse model for dominant collagen VI disorders: heterozygous deletion of Col6a3 Exon 16
TC Pan, RZ Zhang, M Arita, S Bogdanovich, SM Adams, SK Gara, ...
Journal of Biological Chemistry 289 (15), 10293-10307, 2014
382014
HABP2 Mutation and Nonmedullary Thyroid Cancer.
SK Gara, E Kebebew
The New England journal of medicine 373 (21), 2086-2087, 2015
362015
Integrated genome-wide analysis of genomic changes and gene regulation in human adrenocortical tissue samples
SK Gara, Y Wang, D Patel, Y Liu-Chittenden, M Jain, M Boufraqech, ...
Nucleic Acids Research 43 (19), 9327-9339, 2015
332015
Phase I trial of systemic intravenous infusion of interleukin‐13‐Pseudomonas exotoxin in patients with metastatic adrenocortical carcinoma
Y Liu‐Chittenden, M Jain, P Kumar, D Patel, R Aufforth, V Neychev, ...
Cancer medicine 4 (7), 1060-1068, 2015
312015
Lysyl oxidase is a key player in BRAF/MAPK pathway-driven thyroid cancer aggressiveness
M Boufraqech, D Patel, N Nilubol, A Powers, T King, J Shell, J Lack, ...
Thyroid 29 (1), 79-92, 2019
302019
Synergistic combination of flavopiridol and carfilzomib targets commonly dysregulated pathways in adrenocortical carcinoma and has biomarkers of response
N Nilubol, M Boufraqech, L Zhang, K Gaskins, M Shen, YQ Zhang, ...
Oncotarget 9 (68), 33030, 2018
282018
系统目前无法执行此操作,请稍后再试。
文章 1–20